ID   NCH1681
AC   CVCL_A5HV
DR   cancercelllines; CVCL_A5HV
DR   Wikidata; Q107116533
RX   PubMed=29563135;
RX   PubMed=33504762;
CC   Group: Cancer stem cell line.
CC   Sequence variation: Mutation; HGNC; 5382; IDH1; Simple; p.Arg132His (c.395G>A); ClinVar=VCV000156444; Zygosity=Unspecified (PubMed=33504762).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 05-10-23; Version: 5
//
RX   PubMed=29563135; DOI=10.1158/1078-0432.CCR-17-1839;
RA   Dettling S., Stamova S., Warta R., Schnolzer M., Rapp C.,
RA   Rathinasamy A., Reuss D., Pocha K., Roesch S., Jungk C., Warnken U.,
RA   Eckstein V., Grabe N., Schramm C., Weigand M.A., von Deimling A.,
RA   Unterberg A., Beckhove P., Herold-Mende C.;
RT   "Identification of CRKII, CFL1, CNTN1, NME2, and TKT as novel and
RT   frequent T-cell targets in human IDH-mutant glioma.";
RL   Clin. Cancer Res. 24:2951-2962(2018).
//
RX   PubMed=33504762; DOI=10.1038/s41467-020-20752-6;
RA   Lita A., Pliss A., Kuzmin A., Yamasaki T., Zhang L.-M., Dowdy T.,
RA   Burks C., de Val N., Celiku O., Ruiz-Rodado V., Nicoli E.-R.,
RA   Kruhlak M., Andresson T., Das S., Yang C.-Z., Schmitt R.,
RA   Herold-Mende C., Gilbert M.R., Prasad P.N., Larion M.;
RT   "IDH1 mutations induce organelle defects via dysregulated
RT   phospholipids.";
RL   Nat. Commun. 12:614.1-614.16(2021).
//